Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims Databases
Wei et al., medRxiv, doi:10.1101/2022.02.28.22270796
https://c19early.org/wei.html